Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Elisaf

Showing results (211-220 of 248) with videos related to

Pageof 25
Sort By:
Current Medical Research and Opinion|June 3, 2004
Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) StudyVasilios G Athyros, Dimitri P Mikhailidis, Athanasios A Papageorgiou, et al.
Journal of Lipid Research|August 5, 2006
Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemiaSofia G Tsouli, Dimitrios N Kiortsis, Evangelia S Lourida, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2002
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIBVasilis Tsimihodimos, Sonia-Athena P Karabina, Afroditi P Tambaki, et al.
Lipids|October 31, 2006
The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterolIrene F Gazi, Theodosios D Filippatos, Vasilis Tsimihodimos, et al.
Archives of Medical Science : AMS|July 31, 2019
Attainment of cholesterol target values in Greece: results from the Dyslipidemia International Study IIEvangelos Liberopoulos, Loukianos Rallidis, Filio Spanoudi, et al.
Journal of Lipid Research|July 18, 2003
The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activityAnna I Kakafika, Stavroula Xenofontos, Vasilis Tsimihodimos, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 26, 2004
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) studyVasilios G Athyros, Moses Elisaf, Athanasios A Papageorgiou, et al.
Drug Metabolism and Personalized Therapy|October 3, 2014
No effect of CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemiaGeorgia Ragia, Vana Kolovou, Anna Tavridou, et al.
European Heart Journal|August 6, 2015
Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosisBoris Hansel, Ronan Roussel, Yedid Elbez, et al.
Current Drug Targets|March 14, 2007
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levelsVasilios G Athyros, Dimitri P Mikhailidis, Anna I Kakafika, et al.
Pageof 25

Showing results (211-220 of 248) with videos related to

Sort By:
Pageof 25
Current Medical Research and Opinion|June 3, 2004
Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) StudyVasilios G Athyros, Dimitri P Mikhailidis, Athanasios A Papageorgiou, et al.
Journal of Lipid Research|August 5, 2006
Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemiaSofia G Tsouli, Dimitrios N Kiortsis, Evangelia S Lourida, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2002
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIBVasilis Tsimihodimos, Sonia-Athena P Karabina, Afroditi P Tambaki, et al.
Lipids|October 31, 2006
The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterolIrene F Gazi, Theodosios D Filippatos, Vasilis Tsimihodimos, et al.
Archives of Medical Science : AMS|July 31, 2019
Attainment of cholesterol target values in Greece: results from the Dyslipidemia International Study IIEvangelos Liberopoulos, Loukianos Rallidis, Filio Spanoudi, et al.
Journal of Lipid Research|July 18, 2003
The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activityAnna I Kakafika, Stavroula Xenofontos, Vasilis Tsimihodimos, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 26, 2004
Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) studyVasilios G Athyros, Moses Elisaf, Athanasios A Papageorgiou, et al.
Drug Metabolism and Personalized Therapy|October 3, 2014
No effect of CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemiaGeorgia Ragia, Vana Kolovou, Anna Tavridou, et al.
European Heart Journal|August 6, 2015
Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosisBoris Hansel, Ronan Roussel, Yedid Elbez, et al.
Current Drug Targets|March 14, 2007
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levelsVasilios G Athyros, Dimitri P Mikhailidis, Anna I Kakafika, et al.
Pageof 25